Billionaire Marc Lasry’s Latest Stock Picks

AVENUE CAPITALMarc Lasry was one of the highest paid hedge fund managers in 2010. His Avenue Capital Group invests much of its capital in debt, but its recent 13F filing with the SEC disclosed a few long equity positions as well. By looking at the fund’s positions, we think that investors and market watchers can get a feel not only for specific names that Lasry likes but also for what he and his team at Avenue are thinking about the markets. Here are some investment themes that we noticed in the 13F for the quarter ending in September 2012:

The auto industry. Avenue reported equity positions in both General Motors Company (NYSE:GM) and TRW Automotive Holdings Corp. (NYSE:TRW). TRW is a $5.7 billion market cap auto parts company focused on steering, brakes, and safety systems which has risen 41% year to date as the market apparently sees demand for its products picking up in an improved market. Its revenue and earnings were both slightly higher in the third quarter than in the same period in 2011. As with nearly the entire ecosystem around auto companies, its earnings multiples are very low: it trades at trailing and forward P/Es of 6 and 7, respectively. So if TRW can hold its ground financially, it will be a good value (in other words, it does not need to actually improve its current business). GM is not quite in the same boat. It trades at 9 times trailing earnings, with Wall Street analysts expecting growth next year and bringing the forward P/E even with TRW’s at 7. Billionaire David Einhorn had named GM one of his long stock picks at the Value Investing Congress (see more stocks owned by billionaire Einhorn’s Greenlight Capital and read why Einhorn isn’t giving up on GM). Our first impression is that between these two companies we’d rather own TRW; of course, we’d have to build up our confidence in the auto market first.

CIT. The fund sold a small portion of its shares in $7.3 billion market cap commercial lender CIT Group Inc. (NYSE:CIT), but the stock remained a major position in its 13F portfolio. CIT trades at a small discount to the book value of its equity at a P/B ratio of 0.9, though the company has turned in negative earnings so far this year. The sell-side does expect better numbers in 2013, with consensus estimates for the year implying a forward P/E of 10. Bruce Berkowitz’s Fairholme had about $500 million invested in CIT at the end of June, making it one of the fund’s top five holdings by market value (find more of Bruce Berkowitz’s favorite stocks). We might take a closer look at the company, though we’d have to see strong evidence that its bottom line will actually improve.

Magnachip. Lasry and his team added some shares to their stake in semiconductor manufacturer Magnachip Semiconductor Corp (NYSE:MX). Magnachip is valued at about $430 million, though its average daily volume over the last three months has been about 100,000 shares and the current stock price is about $12 (making it possible for most investors to establish a small position if they so choose). Magnachip is down 11% from its IPO levels in March 2011, but now trades at only 5 times earnings (on both a trailing and forward basis). Those valuation statistics do look interesting, though given the company’s small size it might not be worth investigating further.

CIT and GM are becoming popular value plays, but we’re not sure about that either is a stable enough company to be a screaming buy at the current price. TRW looks interesting- cheaper than automakers in general, and with a business that has been performing better recently. It might be a good idea to take a look at that stock and see if it would work in place of buying an automaker like GM or Ford.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!